Deprescribing Advice at Pri-Med West

Video

Many patients, particularly older ones, are taking unnecessary medications.

It is sometimes important to take a step back from a patient’s medication program and decide whether something is necessary or unnecessary.

And for seniors that might be crucial.

In a presentation during Pri-Med West 2022 in Anaheim, Lee A. Lindquist, MD, MPH, Chief of the Division of Geriatrics at Northwestern University Feinberg School of Medicine, spoke about the need to deprescribe when possible, for the senior population.

However, for this to occur correctly there needs to be good communication between the different doctors and specialists.

In an interview with HCPLive®, Lindquist explained her Pri-Med presentation and how a deprescription initiative could work and be beneficial to seniors, particularly as the population is aging.

“So many of our seniors have too many medicines that are not relevant to what they need right now,” Lindquist said.

One of the reasons for the unnecessary medicines is that many people are prescribed medications in their 40s and 50s and continue to take them throughout life, even when they are not entirely necessary.

And the best times to take a look at the treatment schedule and possibly reduce medication is either after a wellness visit or a hospitalization.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.